Announcement PDF 1 | P a g e Doctor Care Anywhere Group PLC (ASX:DOC, “DCA”, “Doctor Care Anywhere” or “the Company”) on 8 May 2026 entered into a binding asset purchase of the A$11 million revenue GLP-1 and medicated weight-loss business of Outcome Diagnostics Limited (“ODL”) and Medic Spot Limited (“MedicSpot”), a leading provider of weight loss solutions to the UK direct to consumer market. The acquisition is not subject to any material conditions precedent. Key terms of the acquisition: • DCA acquires the on-going business of ODL and MedicSpot (“the Business”), a leading provider of medicated weight-loss solutions to the UK market for £850,000 (~A$1.7 million), paid on completion. • This brings in-house a high-performing team with proven direct-to-consumer (“D2C”) and GLP-1 capabilities and significant cross-selling opportunities for Doctor Care Anywhere. • The acquisition will deliver material revenue from day one and is broadly breakeven on standalone EBITDA. Trailing 12 months revenue to March 2026: £5.3 million (~A$11 million) result in a 0.16x EV / Sales multiple for the Business. A key milestone in DCA’s growth strategy. This acquisition is an important step in DCA’s growth plan, as outlined in its FY2025 results and at the AGM on 28 April 2026. It gives DCA an immediate presence in the fast-growing UK weight management market and adds a complementary service that is in strong demand. The sellers are not related parties of DCA, and the transaction does not require shareholder approval under the ASX Listing Rules. The Business also brings an additional, proven platform that DCA will use to accelerate its direct-to-consumer service expansion across the UK. Immediate revenue, funded from existing cash. This asset acquisition adds revenue and momentum from day one. On a trailing 12-month basis to March 2026, the Business generated £5.3 million (~A$11 million) in revenue from its online weight management offering and is broadly breakeven on standalone EBITDA. The £850,000 (~A$1.7 million) purchase price will be funded from DCA’s existing cash balance (£7 million, or ~A$14 million, on 31 March 2026) and ongoing positive operating cash flows. This results in a 0.16x EV / Sales transaction multiple. There is no earn-out, or deferred consideration component, to the acquisition. A proven team with strong execution. Since launching in October 2024, the 11-person ODL weight management team has delivered strong results in a competitive digital market. The Business has grown its active patient base, generated meaningful revenue, and done so with competitive customer acquisition and service costs. DCA is pleased to welcome this high-performing team and the proven direct-to-consumer (“D2C”) capability they bring. In addition to expanding its current GLP-1 business, and cross-selling weight- management services to existing DCA customers, the new team will also help accelerate the D2C offer for DCA’s current virtual GP, mental health, physiotherapy and health assessment products. We also plan to cross-sell DCA’s services to the Business’s clients. Supports our growth initiatives. Together, the two teams are focused on building a larger, fast-growing and profitable consumer health business. John Stier, Chairman of Doctor Care Anywhere, said: “Credit to Laura and the DCA executive leadership team for identifying a strategic acceleration opportunity, moving decisively to secure a transaction in the interests of DCA shareholders, and displaying a clear understanding of how to leverage DCA’s strong trading, rehabilitated balance sheet and market leading position to best advantage.” Laura O’Riordan, CEO of Doctor Care Anywhere, said: “I am delighted to welcome the Medicspot team to DCA! Both teams are excited by the opportunity to grow faster by collaborating. I know we will focus intently over the coming months on integrating the teams and delivering customer growth we believe can follow from strong execution. 11 May 2026 2 | P a g e About Doctor Care Anywhere Doctor Care Anywhere Group PLC is one of the UK’s largest private providers of telehealth services. The Company works with insurers, healthcare providers and corporate customers to connect patients to a range of digitally enabled telehealth services on its proprietary platform. It is committed to delivering the best possible patient experience and clinical care through digitally enabled, joined up, evidence-based pathways. This announcement is made in accordance with Doctor Care Anywhere’s continuous disclosure obligations under the ASX Listing Rules. This announcement has been authorized for release by the Board of Directors of Doctor Care Anywhere Group PLC. Note, as with any acquisition, there are integration and execution risks, which could affect the timetable and results currently expected. There are no other material terms or conditions of the acquisition that a reasonable person would expect to have a material effect on the price or value of Doctor Care Anywhere’s securities. If you are in the UK and want to visit DCA’s newest service: https://www.medicspot.co.uk/